Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Beijing Yu Sheng Tang Pharma signed a MoU to purchase 70%...
China is close to finalizing a draft proposal of a...
China’s 12th Five Year Plan (2011-2015) for...
Fosun Pharma plans a $913 million IPO on the Hong Kong...
It's earnings season, and almost every day for the past...
BeiGene, the Beijing area oncology startup, expects to...
Participants were optimistic about China at last week's...
Over 700 industry leaders from the international...
S*BIO of Singapore sold worldwide rights for a Phase...
Vivo Ventures is the lead investor in a $30 million...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
